Hologic Inc. said 1 million women have undergone its NovaSure global endometrial ablation treatment.
The system is used to treat menorrhagia, or heavy menstrual bleeding, using a 90-second burst of low-frequency radio energy in a roughly 5-minute outpatient procedure.
The Bedford, Mass.-based women’s health products maker said U.S. physicians performed about 312,000 GEA procedures last year, about 205,000 using the NovaSure device, making Hologic’s market share roughly 66 percent.